Ichnos Glenmark to Present Updated Phase 1 Data on ISB 2001 in Multiple Myeloma at ASH 2026
MM Desk
6 November, 2026
Ichnos Glenmark Innovation, Inc (IGI), a clinical-stage biotechnology company focused on developing multispecific therapeutics in